SEC Form 4 · accession 0001127602-15-017644
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Ackerman
Officer — Corporate Executive VP & CFO
Period of report
May 15, 2015
Accepted (ET)
May 18, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | S | 100 | $70.94 | D | 101,635 | D | |
| Common Stock | May 15, 2015 | S | 200 | $70.95 | D | 101,435 | D | |
| Common Stock | May 15, 2015 | S | 200 | $70.96 | D | 101,235 | D | |
| Common Stock | May 15, 2015 | S | 100 | $70.97 | D | 101,135 | D | |
| Common Stock | May 15, 2015 | S | 100 | $71.03 | D | 101,035 | D | |
| Common Stock | May 15, 2015 | S | 100 | $71.10 | D | 100,935 | D | |
| Common Stock | May 15, 2015 | S | 100 | $71.17 | D | 100,835 | D | |
| Common Stock | May 15, 2015 | S | 100 | $71.26 | D | 100,735 | D | |
| Common Stock | May 15, 2015 | S | 100 | $71.39 | D | 100,635 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.